Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project
Author(s) -
Tone Bjørge,
A. Lukanova,
S. Tretli,
Jonas Manjer,
Hanno Ulmer,
Tanja Stocks,
Randi Selmer,
Gabriele Nagel,
Martin Almquist,
H. Concin,
G. Hallmans,
Håkan Jonsson,
Christel Häggström,
P. Stattin,
Anders Engeland
Publication year - 2011
Publication title -
international journal of epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.406
H-Index - 208
eISSN - 1464-3685
pISSN - 0300-5771
DOI - 10.1093/ije/dyr130
Subject(s) - medicine , ovarian cancer , relative risk , metabolic syndrome , cancer , confidence interval , risk factor , oncology , body mass index , gynecology , incidence (geometry) , obesity , physics , optics
No studies have so far evaluated the impact of the metabolic syndrome (MetS) as an entity on ovarian cancer risk. The authors aimed to examine the association between factors in the MetS, individually and combined, and risk of ovarian cancer incidence and mortality.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom